Neuroendocrine-Immune Interactions

New England Journal of Medicine

Volumn 329, Issue 17, 1993, Pages 1246-1253

  Epstein, Franklin H ^a   Reichlin, Seymour ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; CYTOKINE; HORMONE; LYMPHOCYTE RECEPTOR; NEUROPEPTIDE;

ANIMAL; BRAIN; EMOTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; NEUROSECRETION; PATHOPHYSIOLOGY; PERSONALITY; PHYSIOLOGY; REVIEW; ENDOCRINE SYSTEM; HORMONE ACTION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LYMPHOCYTE; NERVOUS SYSTEM; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; NEUROSECRETORY CELL; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY;

ANIMAL; BRAIN; EMOTIONS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS; NEUROTRANSMITTERS; PERSONALITY; RECEPTORS, NEUROTRANSMITTER; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027921994     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199310213291708     Document Type: Review

References (85)

1. Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. San Diego, Calif.: Academic Press, 1991.
2. Benveniste EN. Cytokines: influence on glial cell gene expression and function. In: Blalock JE, ed. Neuroimmunoendocrinology. 2nd ed. Basel, Switzerland: Karger, 1992:84-105.
3. Pober JS, Cotran RS Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-451
4. Dinarello CA, Wolff SM The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106-113
5. Denicoff KD, Rubinow DR, Papa MZ, The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 1987; 107: 293-300
6. Pulliam L, Herndier BG, Tang NM, McGrath MS Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 1991; 87: 503-512
7. Habicht GS, Katona LI, Benach JL Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis 1991; 164: 568-574
8. Snyder SH Nitric oxide: first in a new class of neurotransmitters. Science 1992; 257: 494-496
9. Licinio J, Wong M-L, Gold PW Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology 1991; 129: 562-564
10. Hall NR, McGillis JP, Spangelo BL, Goldstein AL Evidence that thymosins and other biologic response modifiers can function as neuroactive immunotransmitters. J Immunol 1985; 135: Suppl: 806s-811s
11. Gurney ME, Heinrich SP, Lee MR, Yin HS Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 1986; 234: 566-574
12. Breder CD, Dinarello CA, Saper CB Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988; 240: 321-324
13. Lechan RM, Toni R, Clark BD, Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res 1990; 514: 135-140
14. Schobitz B, Voorhuis DA, De Kloet ER Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci Lett 1992; 136: 189-192
15. Altstiel LD, Sperber K Cytokines in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15: 481-495
16. Rada P, Mark GP, Vitek MP, Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats. Brain Res 1991; 550: 287-290
17. Vitkovic L, Kalebic T, de Cunha A, Fauci AS Astrocyte-conditioned medium stimulates HIV-1 expression in a chronically infected promonocyte clone. J Neuroimmunol 1990; 30: 153-160
18. Friedman WJ, Larkfors L, Ayer-LeLievre C, Ebendal T, Olson L, Persson H Regulation of beta-nerve growth factor expression by inflammatory mediators in hippocampal cultures. J Neurosci Res 1990; 27: 374-382
19. Guenard V, Dinarello CA, Weston PJ, Aebischer P Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel. J Neurosci Res 1991; 29: 396-400
20. Ader R, Cohen N. The influence of conditioning on immune responses. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. San Diego, Calif.: Academic Press, 1991:611-46.
21. Mrazek DA, Klinnert M. Asthma: psychoneuroimmunologic considerations. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. San Diego, Calif.: Academic Press, 1991:1013-35.
22. Felten DL, Cohen N, Ader R, Felten SY, Carlson SL, Roszman TL. Central neural circuits involved in neural-immune interactions. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. San Diego, Calif.: Academic Press, 1991:3-25.
23. Sternberg EM, Young WS III, Bernardini R, A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A 1989; 86: 4771-4775
24. Kidd BL, Mapp PI, Gibson SJ, A neurogenic mechanism for symmetrical arthritis. Lancet 1989; 2: 1128-1130
25. De Simoni MG, Sironi M, De Luigi A, Manfridi A, Mantovani A, Ghezzi P Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J Exp Med 1990; 171: 1773-1778
26. Sundar SK, Cierpial MA, Kamaraju LS, Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci U S A 1991; 88: 11246-11250
27. McClain C, Cohen D, Phillips R, Ott L, Young B Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med 1991; 118: 225-231
28. Geschwind N, Behan P Left-handedness: association with immune disease, migraine, and developmental learning disorder. Proc Natl Acad Sci U S A 1982; 79: 5097-5100
29. MacLean D, Reichlin S. Neuroendocrinology and the immune process. In: Ader R, ed. Psychoneuroimmunology. New York: Academic Press, 1981:475-520.
30. Reichlin S. Endocrine-immune interaction. In: DeGroot L, ed. Endocrinology. 3rd ed. Philadelphia: W.B. Saunders (in press).
31. Blalock JE A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 1989; 69: 1-32
32. Weigent DA, Blalock JE Growth hormone and the immune system. Prog Neuroendocrinimmunol 1990; 3: 231-241
33. Kelley KW, Arkins S, Li YM Growth hormone, prolactin, and insulin-like growth factors: new jobs for old players. Brain Behav Immun 1992; 6: 317-326
34. Russell DH New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol Sci 1989; 10: 40-44
35. Riskind PN, Massacesi L, Doolittle TH, Hauser SL The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol 1991; 29: 542-547
36. Schwartz RS, Datta SK. Autoimmunity and autoimmune disease. In: Paul WE, ed. Fundamental immunology. 2nd ed. New York: Raven Press, 1989:819-66.
37. Weiss JM, Sundar S Effects of stress on cellular immune responses in animals. Rev Psychiatry 1992; 11: 145-180
38. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 1985; 135: Suppl: 755s-765s
39. Irwin M, Hauger RL, Jones L, Provencio M, Britton KT Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther 1990; 255: 101-107
40. Payan DG, McGillis JP, Goetz EJ Neuroimmunology. Adv Immunol 1986; 39: 299-323
41. Carr DJ. Neuroendocrine peptide receptors on cells of the immune system. In: Blalock JE, ed. Neuroimmunoendocrinology. 2nd ed. Basel, Switzerland: Karger, 1992:84-105.
42. Crofford LJ, Sano H, Karalis K, Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J Clin Invest 1992; 90: 2555-2564
43. Ottaway CA. Vasoactive intestinal peptide and immune function. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. San Diego, Calif.: Academic Press, 1991:225-62.
44. Lipton JM Modulation of host defense by neuropeptide alpha-MSH. Yale J Biol Med 1990; 63: 173-182
45. Cannon JG, Tatro JB, Reichlin S, Dinarello CA Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 1986; 137: 2232-2236
46. Olsen NJ, Nicholson WE, DeBold CR, Orth DN Lymphocyte-derived adrenocorticotropin is insufficient to stimulate adrenal steroidogenesis in hypophysectomized rats. Endocrinology 1992; 130: 2113-2119
47. DuPont AG, Somers G, Van Steirteghem AC, Warson F, Vanhaelst L Ectopic adrenocorticotropin production: disappearance after removal of inflammatory tissue. J Clin Endocrinol Metab 1984; 58: 654-658
48. Smith EM. Hormonal activities of cytokines. In: Blalock JE, ed. Neuroimmunoendocrinology. 2nd ed. Basel, Switzerland: Karger, 1992:154-69.
49. Kennedy RL, Jones TH Cytokines in endocrinology: their roles in health and in disease. J Endocrinol 1991; 129: 167-178
50. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522-524
51. Munck A, Guyre PM, Holbrook NJ Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984; 5: 25-44
52. Sternberg EM, Chrousos GP, Wilder RL, Gold PW The stress response and the regulation of inflammatory disease. Ann Intern Med 1992; 117: 854-866
53. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992; 35: 1281-1288
54. Demitrack MA, Dale JK, Straus SE, Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224-1234
55. Lechan RM. Update on thyroid releasing hormone. Thyroid Today 1993;16(1).
56. Scarborough DE, Lee SL, Dinarello CA, Reichlin S Interleukin-1 stimulates somatostatin biosynthesis in primary cultures of fetal rat brain. Endocrinology 1989; 124: 549-551 [Erratum, Endocrinology 1989;124:2022.]
57. Pang XP, Hershman JM, Mirell CJ, Pekary AE Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin). Endocrinology 1989; 125: 76-84
58. Koenig JI, Snow K, Clark BD, Intrinsic pituitary interleukin-1 beta is induced by bacterial lipopolysaccharide. Endocrinology 1990; 126: 3053-3058 [Erratum, Endocrinology 1990;127:657.]
59. Vankelecom H, Carmeliet P, Van Damme J, Billiau A, Denef C Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 1989; 49: 102-106
60. Romero LI, Lechan RM, Clark BD, Dinarello CA, Reichlin S. IL-1 receptor antagonist inhibits h IL-1 beta but not bacterial lipopolysaccharide (LPS) stimulated IL-6 secretion by rat anterior pituitary cells. In: Program and abstracts of the 73rd Annual Meeting of the Endocrine Society, Washington, D.C., June 19-22, 1991. Bethesda, Md.: Endocrine Society, 1991:150. abstract.
61. Reichlin S, Glaser RJ Thyroid function in experimental streptococcal pneumonia in the rat. J Exp Med 1958; 107: 219-236
62. Gardner DF, Kaplan MM, Stanley CA, Utiger RD Effect of triiodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 1979; 300: 579-584
63. Brent GA, Hershman JM Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63: 1-8
64. Skinner MK Cell-cell interactions in the testis. Endocr Rev 1991; 12: 45-77
65. Adashi EY The potential relevance of cytokines to ovarian physiology: the emerging role of resident ovarian cells of the white blood cell series. Endocr Rev 1990; 11: 454-464
66. Rivier C, Rivest S Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol Reprod 1991; 45: 523-532
67. Shalts E, Feng Y-J, Ferin M Vasopressin mediates the interleukin-1 alpha-induced decrease in luteinizing hormone secretion in the ovariectomized rhesus monkey. Endocrinology 1992; 131: 153-158
68. Cousins N. Anatomy of an illness as perceived by the patient: reflections on healing and regeneration. New York: W.W. Norton, 1979.
69. Kiecolt-Glaser JK, Glaser R. Stress and immune function in humans. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. San Diego, Calif.: Academic Press, 1991:849-67.
70. Kasl SV, Evans AS, Niederman JC Psychosocial risk factors in the development of infectious mononucleosis. Psychosom Med 1979; 41: 445-466
71. Antoni MH, Schneiderman N, Klimas N, LaPerriere A, Ironson G, Fletcher MA Disparities in psychological, neuroendocrine, and immunologic patterns in asymptomatic HIV-1 seropositive and seronegative gay men. Biol Psychiatry 1991; 29: 1023-1041
72. Simonton OC. Getting well again: a step-by-step, self-help guide to overcoming cancer for patients and their families. Los Angeles: J.P. Tarcher, 1978.
73. Siegel BS. Love, medicine & miracles: lessons learned about self-healing from a surgeon's experience with exceptional patients. New York: Harper & Row, 1990.
74. Stein M, Miller AH, Trestman RL Depression, the immune system, and health and illness. Arch Gen Psychiatry 1991; 48: 171-177
75. Evans DL, Folds JD, Petitto JM, Circulating natural killer cell phenotypes in men and women with major depression: relation to cytotoxic activity and severity of depression. Arch Gen Psychiatry 1992; 49: 388-395
76. Irwin M, Patterson T, Smith TL, Reduction of immune function in life stress and depression. Biol Psychiatry 1990; 27: 22-30
77. Irwin M, Smith TL, Gillin JC Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosom Med 1992; 54: 10-21
78. Spiegel D, Bloom JR, Kraemer HC, Gottheil E Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2: 888-891
79. Fawzy FI, Fawzy NW, Hyun CS, Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993; 50: 681-689
80. Fawzy FI, Kemeny ME, Fawzy NW, A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 1990; 47: 729-735
81. Martin RL, Cloninger CR, Guze SB, Clayton PJ Mortality in a follow-up of 500 psychiatric outpatients. II. Cause-specific mortality. Arch Gen Psychiatry 1985; 42: 58-66
82. Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 1985; 312: 1551-1555
83. Persky VW, Kempthorne-Rawson J, Shekelle RB Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosom Med 1987; 49: 435-449
84. Zonderman AB, Costa PT Jr, McCrae RR Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA 1989; 262: 1191-1195
85. Rabkin JG, Williams JB, Remien RH, Goetz R, Kertzner R, Gorman JM Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry 1991; 48: 111-119